Veradermics Reports Positive Phase 3 VDPHL01 Topline Results
Veradermics said VDPHL01 produced hair-count increases of up to 36.4 hairs/cm², with no treatment-related serious adverse events.
Veradermics reported positive Phase 3 topline results for VDPHL01 showing statistically significant hair growth and a favorable safety profile.Key Highlights:Original SEC Filing: Veradermics, Inc [ MANE ] - 8-K - Oct. 19, 2026This is an AI-powered summary. It may contain inaccuracies. Consider veri…